Osteoarthritis (OA) is a complex, multifactorial disease influenced by genetic, environmental, and biomechanical factors. To advance personalized treatment strategies, the PROBE consortium’s team, led by Helmholtz Munich, has conducted a comprehensive review of the latest genetic research in OA, now published in Osteoarthritis and Cartilage. This review lays the foundation for PROBE’s work in: Identifying [...]

The PROBE consortium officially kicked off its groundbreaking initiative with a two-day meeting in Rotterdam on January 12-13, 2026. The event brought together leading academic institutions, industry partners, and stakeholders to align on the project’s vision: transforming osteoarthritis (OA) treatment through federated big data, AI-driven innovation, and patient-centered clinical strategies. The meeting began with welcoming [...]